Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MODD |
---|---|---|
10:24 ET | 100 | 1.725 |
10:32 ET | 100 | 1.7392 |
10:39 ET | 750 | 1.72 |
10:53 ET | 100 | 1.69 |
12:03 ET | 5460 | 1.67 |
12:21 ET | 100 | 1.68 |
12:34 ET | 300 | 1.695 |
12:45 ET | 250 | 1.7099 |
12:50 ET | 100 | 1.68 |
01:10 ET | 200 | 1.685 |
01:12 ET | 300 | 1.68 |
01:14 ET | 300 | 1.68 |
01:15 ET | 200 | 1.68 |
01:17 ET | 300 | 1.676 |
01:19 ET | 200 | 1.68 |
01:21 ET | 400 | 1.67 |
01:24 ET | 400 | 1.67 |
01:26 ET | 200 | 1.67 |
01:28 ET | 300 | 1.66 |
01:30 ET | 200 | 1.66 |
01:33 ET | 300 | 1.66 |
01:50 ET | 100 | 1.64 |
02:08 ET | 100 | 1.64 |
02:29 ET | 6690 | 1.6211 |
02:36 ET | 300 | 1.6573 |
02:44 ET | 100 | 1.62 |
02:47 ET | 466 | 1.6201 |
03:07 ET | 100 | 1.62 |
03:36 ET | 100 | 1.6599 |
03:45 ET | 200 | 1.63 |
03:54 ET | 200 | 1.63 |
03:56 ET | 100 | 1.66 |
03:57 ET | 160 | 1.64 |
03:59 ET | 523 | 1.63 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Modular Medical Inc | 50.5M | -1.7x | --- |
United Health Products Inc | 50.0M | -18.3x | --- |
Beyond Air Inc | 56.5M | -0.6x | --- |
InspireMD Inc | 49.0M | -1.9x | --- |
Medinotec Inc | 58.7M | -103.5x | --- |
Lucid Diagnostics Inc | 38.4M | -0.6x | --- |
Modular Medical, Inc. is a development stage, medical device company. The Company is focused on the design, development, and commercialization of an insulin pump using modernized technology to increase pump adoption in the diabetes marketplace. The Company, through the creation of two-part patch pump, MODD1, seeks to serve both the type 1 and type 2 diabetes markets. The Company, using its methods of insulin measurement, is able to eschew complex mechanisms and instead build a product candidate using only parts from high volume consumer electronics manufacturing lines. It provides an insulin pump, which has both basal (steady flow) and bolus (mealtime dosing) insulin disbursement. It also consists of a natural migration path to multi-chamber/multi-liquid pumps, potentially offering an array of new therapies to patients with diabetes and other conditions.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $50.5M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 31.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.19 |
EPS | $-0.97 |
Book Value | $0.46 |
P/E Ratio | -1.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.